Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors Portfolio 13F
Ole Andreas Halvorsen Holdings Activity
- Portfolio value:
- $36.46B≈ (+$3B≈)
- Previous value:
- $32.98B≈
- # of changes:
- 101
- New positions:
- 25
- Reported for:
- 30 Sep 2021 (Q3)
- Latest filing date:
- 16 May 2022
Viking Global Investors has disclosed a total of 101 changes to the portfolio in the (2021 Q3) SEC report(s): increased the number of shares of 26, bought 25 totally new, decreased the number of shares of 33 and completely sold out 17 position(s).
What stocks did Ole Andreas Halvorsen buy in 2021 Q3?
During 2021 Q3 Ole Andreas Halvorsen has bought 51 securities out of which top 5 purchases (by % change to portfolio) were (DNA) Ginkgo Bioworks Holdings (new buy), (GE) GE Aerospace (added shares +47.50%), (TMUS) T-Mobile US Inc (added shares +35.57%), (HUM) Humana Inc (added shares +411.17%) and (BN) Brookfield Corp (added shares +311.25%).
101 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Activision Blizzard Inc
|
new
|
+796,247
|
796,247
|
+0.17%
|
$77.39
|
|
0.17%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Atea PharmaceuticalsInc
|
new
|
+1,655,087
|
1,655,087
|
+0.16%
|
$35.06
|
-86.81%($4.62)
|
0.16%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Canadian Pacific Kansas City Limited
|
new
|
+3,447,633
|
3,447,633
|
+0.62%
|
$65.07
|
+37.14%($89.24)
|
0.62%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Celldex Therapeutics Inc
|
new
|
+762,296
|
762,296
|
+0.11%
|
$53.99
|
-30.07%($37.76)
|
0.11%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Comcast Corp
|
new
|
+10,176,623
|
10,176,623
|
+1.56%
|
$55.93
|
-55.99%($24.62)
|
1.56%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
FARFETCH LTD, CL-A
|
new
|
+11,538,035
|
11,538,035
|
+1.19%
|
$37.48
|
-100.00%($0.00)
|
1.19%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Ginkgo Bioworks Holdings
|
new
|
+339,055,144
|
339,055,144
|
+10.78%
|
$11.59
|
-23.38%($8.88)
|
10.78%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
HDFC Bank Limited ADR
|
new
|
+1,679,130
|
1,679,130
|
+0.34%
|
$73.09
|
-67.10%($24.04)
|
0.34%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Icosavax Inc
|
new
|
+1,852,789
|
1,852,789
|
+0.15%
|
$29.59
|
|
0.15%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Illumina Inc
|
new
|
+155,319
|
155,319
|
+0.17%
|
$405.61
|
-50.88%($199.23)
|
0.17%
|
2021 Q3
|
≈ 0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.